Ocular Presentation of Behcet’s Syndrome Associated with Covid-19 Vaccination |Biomedgrid
Journal: American Journal of Biomedical Science & Research (Vol.15, No. 6)Publication Date: 2022-03-17
Authors : Voichanski Shilo; Shaer Boaz;
Page : 649-652
Keywords : Behcet’s Syndrome; COVID-19 Vaccination; Bilateral vitritis; Pathognomonic; Hemorrhages;
Abstract
Purpose: To shed some light on the long debate as to whether autoimmune diseases might also be triggered by vaccines, through the immune cross-reactivity mechanism.
Observations: We report a case of bilateral pan uveitis and vasculitis, being a first presentation of Behcet syndrome in a young healthy patient who received COVID-19 vaccine. The vaccine might have triggered de novo ocular inflammatory process or ocular exacerbation of an impending Behcet disease, through the immune cross-reactivity mechanism. The patient was treated with oral prednisone and azathioprine with good response. Conclusions and Importance: In our case it might be due to de novo ocular inflammatory process or due to ocular exacerbation of an impending Behcet disease, both might have been triggered by the COVID-19 vaccine the patient received It is important for clinicians to be aware of the association we encountered, and for future post-marketing studies of COVID-19 vaccine to address it.
Other Latest Articles
- Role of Tumor Microenvironment in Cancer Stem Cell and Clinical Application |Biomedgrid
- Review: Communicating Public Health Intervention to Newcomers to Canada |Biomedgrid
- TB Diagnostics: Existing Platform and Future Direction |Biomedgrid
- Uvular Necrosis from a Traumatic Bronchoscopy |Biomedgrid
- Antioxidant Activity of Single Black Garlic (Allium sativum L.) Ethanol Extract and Its Potential for Oral and Dental Health
Last modified: 2024-02-08 21:44:17